Common Stock, Shares, Outstanding of ROCKET PHARMACEUTICALS, INC. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ROCKET PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • ROCKET PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 108,319,783, a 1.8% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ROCKET PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 108,319,783 +1,865,965 +1.8% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 108,208,643 +17,091,951 +19% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 107,884,420 +16,927,807 +19% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 106,753,886 +16,107,296 +18% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 106,453,818 +16,171,551 +18% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 91,116,692 +970,090 +1.1% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 90,956,613 +10,437,769 +13% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 90,646,590 +10,236,967 +13% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 90,282,267 +11,161,526 +14% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 90,146,602 +22,307,799 +33% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 80,518,844 +14,680,950 +22% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 80,409,623 +15,887,566 +25% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 79,120,741 +14,614,852 +23% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 67,838,803 +3,396,202 +5.3% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 65,837,894 +2,389,825 +3.8% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 64,522,057 +2,534,258 +4.1% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 64,505,889 +3,509,522 +5.8% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 64,442,601 +9,241,495 +17% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 63,448,069 +8,278,066 +15% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 61,987,799 +6,861,325 +12% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 60,996,367 +6,227,337 +11% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 55,201,106 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 55,170,003 +4,837,568 +9.6% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 55,126,474 +10,012,037 +22% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 54,769,030 +9,624,294 +21% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q2 2019 50,332,435 +10,825,908 +27% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 45,114,437 +5,710,539 +14% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 45,144,736 +38,349,109 +564% 31 Dec 2018 10-K 06 Mar 2020 2019 FY
Q3 2018 39,835,500 +12,612,755 +46% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 39,506,527 +12,496,325 +46% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 39,403,898 +12,417,580 +46% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 6,795,627 +49,048 +0.73% 31 Dec 2017 10-K 08 Mar 2019 2018 FY
Q3 2017 27,222,745 +292,015 +1.1% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 27,010,202 +79,472 +0.3% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 26,986,318 +562,924 +2.1% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 6,746,579 -19,676,815 -74% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 26,930,730 +520,479 +2% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 26,930,730 +10,603,727 +65% 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 26,423,394 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 26,423,394 +25,403,306 +2490% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 26,410,251 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 16,327,003 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q4 2014 1,020,088 31 Dec 2014 10-K 23 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.